Tehran Heart Center Hospital

Tehran Heart Center (THC) is a leading cardiovascular hospital in Iran and the Middle East. Here are some key points about its history and introduction:

THC was inaugurated in 2001 in central Tehran, Iran. It is affiliated with the Tehran University of Medical Sciences.
With 470 beds, 11 open heart surgery rooms, and 6 catheterization labs, THC is one of the largest and best-equipped cardiac hospitals in the region.
The center performs over 3,500 heart surgeries and 15,000 specialized cardiac procedures annually.
THC offers comprehensive cardiovascular services, including specialized clinics, imaging (echocardiography, CT, MRI, nuclear scans), cardiac rehabilitation, and advanced diagnostic labs.
It is a major academic center that trains specialized assistants and fellows in various cardiovascular fields each year.
THC is actively involved in cardiovascular research, with 11 disease-specific databases and facilities for clinical and experimental studies.
The center publishes over 110 scientific articles annually in international journals.
THC publishes its quarterly scientific journal indexed in PubMed.
With about 1,400 staff including doctors, nurses, and technicians, THC follows international quality standards and has obtained ISO 9001:2000 certification.
The Tehran Heart Center’s Premature Coronary Atherosclerosis Cohort Study (THC-PAC) is the first of its kind in the Middle East to assess major adverse cardiac events in young coronary artery disease patient.
THC has an International Patient Department to provide services for patients from other countries.

Gallery

Languages

English
Persian

Morning

Monday:
Tuseday:
Wednesday:
Thursday:
Friday:
Saturday:
Sunday:
–
–
–
–
–
–
–

Evening

Monday:
Tuseday:
Wednesday:
Thursday:
Friday:
Saturday:
Sunday:
–
–
–
–
–
–
–

1. What are the most common cardiovascular diseases treated at Tehran Heart Center?

Tehran Heart Center (THC) treats a wide range of cardiovascular diseases. , we can infer some key points: Coronary Artery Disease (CAD): THC has a significant focus on treating CAD, especially in younger patients. The Tehran Heart Center's Premature Coronary Atherosclerosis Cohort Study (THC-PAC) specifically examines CAD in males ≤45 years old and females ≤55 years old. Atherosclerosis: As evident from the THC-PAC study, premature coronary atherosclerosis is a major area of focus for the center. Conditions requiring open heart surgery: The center performs over 3,500 heart surgeries annually, indicating treatment of conditions that require surgical intervention. Conditions requiring catheterization: With 6 catheterization labs and over 15,000 specialized cardiac procedures performed annually, THC likely treats a high volume of patients requiring interventional cardiology procedures. Arrhythmias: The center has departments for arrhythmia and syncope, suggesting these are common conditions treated. Heart failure: As a comprehensive cardiac care center, heart failure is likely a common condition treated, though not explicitly mentioned in the search results. Hypertension: The search results indicate that 46.7% of patients in the THC-PAC study had hypertension, suggesting it's a common condition treated at the center. Hyperlipidemia: 71.8% of patients in the THC-PAC study had hyperlipidemia, indicating it's frequently addressed at THC.

2. How does Tehran Heart Center manage obesity-related cardiovascular diseases?

Tehran Heart Center (THC) employs a comprehensive approach to manage obesity-related cardiovascular diseases, leveraging both clinical and research-based strategies: Clinical Management Comprehensive Cardiovascular Services: THC provides a wide range of cardiovascular services, including specialized clinics for arrhythmia, syncope, and hypertension, which are often associated with obesity. The center's facilities include advanced diagnostic and treatment options such as echocardiography, CT scans, MRI, and nuclear scans. Surgical and Interventional Procedures: With 11 open heart surgery rooms and 6 catheterization labs, THC performs over 3,500 heart surgeries and 15,000 specialized cardiac procedures annually, addressing severe cardiovascular conditions that may arise from obesity. Cardiac Rehabilitation: THC offers modern cardiac rehabilitation services, which are crucial for managing and mitigating the effects of obesity on cardiovascular health. These programs typically include exercise training, dietary counseling, and lifestyle modifications. Research and Education Obesity and Cardiovascular Risk Factors Study: The Tehran Lipid and Glucose Study, which included 15,005 participants, identified significant correlations between obesity and cardiovascular risk factors such as hypertension, high cholesterol, and high triglycerides. This study underlines the importance of lifestyle changes and education in managing obesity-related cardiovascular diseases. Premature Coronary Atherosclerosis Cohort Study (THC-PAC): This study focuses on young patients with coronary artery disease, a condition often exacerbated by obesity. The study highlights the prevalence of obesity among these patients and underscores the need for targeted interventions. Publication and Dissemination: THC is active in publishing research, with over 110 scientific articles annually in international journals. The center's own quarterly scientific journal, indexed in PubMed, disseminates findings related to obesity and cardiovascular health, contributing to global knowledge and best practices. Preventive Measures Lifestyle Modification Programs: THC emphasizes the importance of lifestyle changes in managing obesity-related cardiovascular diseases. This includes dietary counseling, physical activity promotion, and smoking cessation programs. Patient Education: THC provides education about the risks of obesity and the importance of maintaining a healthy weight. This is aimed at both preventing the onset of cardiovascular diseases and managing existing conditions. By integrating advanced clinical care, comprehensive research, and preventive education, Tehran Heart Center effectively manages obesity-related cardiovascular diseases, improving patient outcomes and contributing to the broader understanding of these conditions.

Tehran Heart Center Hospital

Languages

Send a ReviewCancel ×